Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Differential Expression of the Aryl Hydrocarbon Receptor and Transforming Growth Factor Beta 1 in Chronic Rhinosinusitis with Nasal Polyps with Allergic Rhinitis

Chen L. · Xiao L. · Liu J. · Shen Y. · Ke X. · Huang J. · Hu G. · Yang Y.

Author affiliations

Department of Otorhinolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Related Articles for ""

ORL 2017;79:295-305

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 09, 2017
Accepted: September 11, 2017
Published online: November 29, 2017
Issue release date: Published online first (Issue-in-Progress)

Number of Print Pages: 11
Number of Figures: 4
Number of Tables: 1

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL

Abstract

Objective: This study aimed to determine the aryl hydrocarbon receptor (AhR) and transforming growth factor beta 1 (TGF-β1) expression levels in chronic rhinosinusitis (CRS) and their possible correlation with allergic state and tissue remodeling. Methods: Patients were enrolled and divided into the following groups: CRS without nasal polyps (NP) without allergic rhinitis (AR) (CRSsNPsAR; n = 20), CRS with NP with AR (CRSwNPwAR; n = 20), CRS with NP without AR (CRSwNPsAR; n = 20), and controls (n = 15). Tissue samples were analyzed by Masson trichrome staining for collagen, while the location and expression of AhR and TGF-β1 were analyzed by immunohistochemistry, quantitative reverse transcription polymerase chain reaction (qRT-PCR), and Western blotting. Results: The collagen amounts as well as AhR and TGF-β1 mRNA and protein expression levels were significantly increased in the CRSsNPsAR group compared with the CRSwNP (CRSwNPsAR and CRSwNPwAR) samples (p < 0.01). However, higher collagen amounts (p < 0.05) and higher TGF-β1 (p < 0.05) but lower AhR expression levels (p < 0.05) were detected in the CRSwNPwAR versus the CRSwNPsAR patients. Both AhR and TGF-β1 expression were positively correlated with the collagen level in CRS samples (p < 0.01). Conclusions: Elevated AhR expression may be involved in the progression of tissue remodeling in CRSsNPsAR similar to TGF-β1 expression. Conversely, lower AhR expression may be involved in allergic reactions in CRSwNPwAR.

© 2017 S. Karger AG, Basel


References

  1. Kou W, Hu GH, Yao HB, Wang XQ, Shen Y, Kang HY, et al: Regulation of transforming growth factor-β1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec 2012;74:172-178.
  2. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al: EPOS 2012: European Position Paper on Rhinosinusitis and Nasal Polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012;50:1-12.
  3. Bachert C, Zhang N, van Zele T, Gevaert P: Chronic rhinosinusitis: from one disease to different phenotypes. Pediatr Allergy Immunol 2012;23(suppl 22):2-4.
  4. Yang YC, Zhang N, van Crombruggen K, Hu GH, Hong SL, Bachert C: Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012;67:1193-1202.
  5. Yang Y, Zhang N, van Crombruggen K, Lan F, Hu G, Hong S, et al: Differential expression and release of activin A and follistatin in chronic rhinosinusitis with and without nasal polyps. PLoS One 2015;10:e0128564.
  6. Krause HF: Allergy and chronic rhinosinusitis. Otolaryngol Head Neck Surg 2003;128:14-16.
  7. Feng H, Yang Y, Zhou H, Bai S: To study of the nasal mucosa remodeling of allergic rhinitis patients (in Chinese). Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012;26:205-208.
    External Resources
  8. Yang Y, Zhang N, Lan F, van Crombruggen K, Fang L, Hu G, et al: Transforming growth factor-beta 1 pathways in inflammatory airway diseases. Allergy 2014;69:699-707.
  9. van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, et al: TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009;124:253-259, 259.e1-e2.
  10. Esser C, Rannug A: The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol Rev 2015;67:259-279.
  11. Wei P, Hu GH, Kang HY, Yao HB, Kou W, Zhang C, et al: Role of the aryl hydrocarbon receptor in the pathogenesis of chronic rhinosinusitis with nasal polyps. Inflammation 2014;37:387-395.
  12. Pawankar R, Bunnag C, Khaltaev N, Bousquet J: Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008. World Allergy Organ J 2012;5(suppl 3):S212-S217.
  13. Li W, Yan S, Zhao J, Ding X, Zhang S, Wang D, et al: Metoprolol inhibits cardiac apoptosis and fibrosis in a canine model of chronic obstructive sleep apnea. Cell Physiol Biochem 2015;36:1131-1141.
  14. Li Y, Shi J, Yang BF, Liu L, Han CL, Li WM, et al: Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol. Br J Pharmacol 2012;165:1748-1756.
  15. Liu K, Shen C, Chen X: Expression of androgen receptor in coronary artery in the cases of sudden coronary death. Int J Clin Exp Pathol 2015;8:3742-3747.
    External Resources
  16. Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, Burns EJ, et al: An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2010;107:20768-20773.
  17. Monteleone I, Zorzi F, Marafini I, Di Fusco D, Dinallo V, Caruso R, et al: Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut. Eur J Immunol 2016;46:1047-1057.
  18. Poormasjedi-Meibod MS, Salimi Elizei S, Leung V, Baradar Jalili R, Ko F, Ghahary A: Kynurenine modulates MMP-1 and type-I collagen expression via aryl hydrocarbon receptor activation in dermal fibroblasts. J Cell Physiol 2016;231:2749-2760.
  19. Chuang CY, Chang H, Lin P, Sun SJ, Chen PH, Lin YY, et al: Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer. Gene 2012;492:262-269.
  20. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, et al: Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995;268:722-726.
  21. Wei P, Hu GH, Kang HY, Yao HB, Kou W, Liu H, et al: Increased aryl hydrocarbon receptor expression in patients with allergic rhinitis. QJM 2014;107:107-113.
  22. Wang H, Zhang L, Zhou B, Zhang W, Liu HC, Liu M, et al: Relationship between allergic factors and chronic sinusitis with or without nasal polyps (in Chinese). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2005;40:168-171.
    External Resources
  23. Stevens WW, Schleimer RP, Kern RC: Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 2016;4:565-572.
  24. Kung T, Murphy KA, White LA: The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochem Pharmacol 2009;77:536-546.
  25. Gomez-Duran A, Ballestar E, Carvajal-Gonzalez JM, Marlowe JL, Puga A, Esteller M, et al: Recruitment of CREB1 and histone deacetylase 2 (HDAC2) to the mouse Ltbp-1 promoter regulates its constitutive expression in a dioxin receptor-dependent manner. J Mol Biol 2008;380:1-16.
  26. Chang X, Fan Y, Karyala S, Schwemberger S, Tomlinson CR, Sartor MA, et al: Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol 2007;27:6127-6139.
  27. Lehmann GM, Xi X, Kulkarni AA, Olsen KC, Pollock SJ, Baglole CJ, et al: The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation. Am J Pathol 2011;178:1556-1567.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 09, 2017
Accepted: September 11, 2017
Published online: November 29, 2017
Issue release date: Published online first (Issue-in-Progress)

Number of Print Pages: 11
Number of Figures: 4
Number of Tables: 1

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.